AIZN vs ALNY · $9.38B cap vs P/E 76, rev $1.29B
Assurant, Inc. 5.25% Subordinat (AIZN) versus Alnylam Pharmaceuticals Inc (ALNY) — a side-by-side from cached financials, not a winner call.
Assurant, Inc. 5.25% Subordinat (AIZN) common stock listed on US.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
AIZN does not have a complete income-statement cache yet.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
AIZN currently screens at market cap $9.38B. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Not investment advice. Open the AIZN and ALNY stock pages for the full models.
Not investment advice.